Get 50% OFF This Monsoon!
Nidan Laboratories & Healthcare
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
The Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, name of the Company changed from 'Abhi Diagnostic Imagings Private Limited' to 'Nidan Laboratories And Healthcare Private Limited' under the Companies Act, 2013 pursuant to a Special Resolution passed by Shareholders at the EGM held on February 26, 2021 and had obtained fresh Certificate of Incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, Company got converted into a Public Limited Company and name of the Company was changed to Nidan Laboratories And Healthcare Limited' and a fresh Certificate of Incorporation consequent upon conversion to Public Limited Company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021. The Company carry on the business of Diagnostic Centre, such as X-Ray, Sonography, 2 D ECHO, PFT, CST, C.T. Scan, MRI etc., Blood Bank, Pathology Laboratories, Dialysis Unit, Intensive Care Unit, Burn & Poisoning Centre and Poly Clinic.
Nidan was established as a Proprietary Firm in 1994 by Promoter, Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The Company came into existence in the year 2000. The business was carried out under the sole proprietorship, which was later taken over by the Company in 2000. From the year 2000 onwards, he expanded the diagnostic's business by setting up various centres within the Northern District of Mumbai and Pune and Southern District of Pune. Nearly 30 diagnostic cum collection centres are operational under the brand name of 'Nidan Healthcare' and offer radiology, neurology, cardiology, dental as well as pathology services. Out of the 35 Centre's, 16 centre's are under the Franchisee model where 1 centre acts as a fully operated diagnostic centre and 15 centres act solely as standalone collection centres. The Company provide integrated diagnostics services to more than 1 million patients per year.
To enable the patients easily distinguish its pathology and radiology services, the Company introduced 'NIDANPATH' and 'NIDAN DIAGNOSTICS' respectively in the year 2017. Since 2000, private and government hospitals have been using the services and diagnostics centres for various pathology and radiology tests. The Company successfully set its diagnostics centre in Asian Heart Hospital, Mumbai under the name of 'Asian Nidan Imaging Centre'. The Company offer a comprehensive range of approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines.
The diagnostic services of Nidan are provided by a medical professional team consisting of 94 laboratory doctors, radiologists, physicians and 256 well-trained technical staff in the operational network. All of the Company centres are Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) accreditations. The diagnostic centres of the Company are designed in accordance with certain specifications, which include requirements in relation to design of work area, physical infrastructure and placement of technical equipment. The Company specializes in all diagnostic services under one roof consisting of all kind of Pathological tests of Blood, Urine, Stool, etc., Radiological tests like CT Scan, MRI, X-Ray, Ultrasound Sonography, Cardiological Tests like ECG, Stress Test, 2 D Echo, etc., Neurological Test like EMG, EEG, etc.
The Company test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays and ultrasounds to advanced radiology tests including computerized tomography (CT) scans and magnetic resonance imaging (MRI) scans. The Company offer a broad spectrum of health and wellness packages to customers as per their requirements. It focus on a customer centric approach to enhance the overall quality of services for optimal customer satisfaction. For convenience of the customers, Nidan Labs & Healthcare provide value-added services such as home collection of specimens, house calls and various delivery or access modes, i.e., at diagnostic Centre's, SMS, email, web and mobile portal for test reports. Several factors, including the strength of its brand, integrated services model, quality of diagnostic services, center infrastructure and customer experience, convenience of operational network and home collection in core geographies are the important differentiating factors in customer choosing clients as their preferred diagnostic service provider, which helps them in retaining customers, and sets them apart from its competitors.
The Company gained best name in radiology as well as in pathology. As part of it, the Company has also tied up with best pathology Partners like Metropolis Laboratories Limited. It introduced a wide range of home visit sources not limited to pathology only, which includes Pathology-ECG, EEG, EMG, BMD, X-Rays, AMBP and Cardiac Holter; introduced 'No Profit-Affordable Health Model' and Packages wherein it offer services at a discounted rate. The Company has come out with unique appointment booking mobile application under the name of 'NIDAN HEALTHCARE' which is supported by self-indigenous software called 'Nidan Operation Management (NOM).' This unique app enables the patients to book appointments 'For Any test. From Anywhere. At Any-time. By choosing particular time slot for test. By knowing the exact cost of test. By paying the exact amount online. By getting the exact instructions of preparation for particular test.'
The Company intends to introduce online Health Care Consultancy Services, Health Care Services (Medical), Hospital And Diagnostic Services under the brand name 'HEALTHEXPEDIA', 'TRUFIT CLINIC' and 'NIDAN HEALTHMALL'. The introduction of these strategies which have been widely accepted patients, especially in the era of Covid-19, have assisted the Company in changing the dynamisms of its business and traditional way of booking appointments and conducting tests. With the largest and fastest growing diagnostic chain with dominant position in Northern District of Mumbai, the Company is well positioned to leverage the high growth in Indian diagnostics industry.
Keeping this in mind, the Company proposes to expand diagnostic and collection centres PAN Mumbai by entering into Joint Ventures with various Laboratories such as Metropolis Healthcare Limited, SRL Diagnostics, etc., on the terms and conditions as agreed between the parties. The Company has entered into a APSC Agreement with Metropolis Healthcare Limited as well and over the next 5 years, intends to set up more centres PAN India, either by acquiring brown field projects especially in Rajasthan, Punjab or by using 'Hub and Spoke Model' within the Metro cities of India.
In 2019, the Company received several awards that recognized the strength of its brand and focused on offering superior diagnostic services. For examples, Nidan was recognized as Best Diagnostic Chain of India Award 2019, in Category of over 20 + diagnostic centres by Express Healthcare Division of The Indian Express Group. The Company also earned a reputation among its clients by winning several accolades and client appreciation that testify the commitment levels and effective deliveries of good work.
Nidan Laboratories & Healthcare share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Nidan Laboratories & Healthcare indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Nidan Laboratories & Healthcare is valued compared to its competitors.
Nidan Laboratories & Healthcare PE ratio helps investors understand what is the market value of each stock compared to Nidan Laboratories & Healthcare 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Nidan Laboratories & Healthcare evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Nidan Laboratories & Healthcare generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Nidan Laboratories & Healthcare in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Nidan Laboratories & Healthcare shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Nidan Laboratories & Healthcare compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Nidan Laboratories & Healthcare over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Nidan Laboratories & Healthcare helps investors get an insight into when they can enter or exit the stock. Key components of Nidan Laboratories & Healthcare Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Nidan Laboratories & Healthcare shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Nidan Laboratories & Healthcare ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Nidan Laboratories & Healthcare provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Nidan Laboratories & Healthcare highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Nidan Laboratories & Healthcare .
The balance sheet presents a snapshot of Nidan Laboratories & Healthcare ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.